Sputnik V uses two different disarmed strains of the adenovirus, a virus that causes the common cold, as vectors to deliver the vaccine dose. Photo: EPA-EFE Sputnik V uses two different disarmed strains of the adenovirus, a virus that causes the common cold, as vectors to deliver the vaccine dose. Photo: EPA-EFE
Sputnik V uses two different disarmed strains of the adenovirus, a virus that causes the common cold, as vectors to deliver the vaccine dose. Photo: EPA-EFE

Coronavirus: Russia’s Sputnik V vaccine 91.6 per cent effective, British study says

  • Sputnik V was approved in Russia months before results from its final-stage clinical trials were published, leading to scepticism from experts
  • But the new analysis of data from 20,000 participants in Phase 3 trials suggests the shot offers strong efficacy against symptomatic Covid-19

Topic |   Coronavirus pandemic
Sputnik V uses two different disarmed strains of the adenovirus, a virus that causes the common cold, as vectors to deliver the vaccine dose. Photo: EPA-EFE Sputnik V uses two different disarmed strains of the adenovirus, a virus that causes the common cold, as vectors to deliver the vaccine dose. Photo: EPA-EFE
Sputnik V uses two different disarmed strains of the adenovirus, a virus that causes the common cold, as vectors to deliver the vaccine dose. Photo: EPA-EFE
READ FULL ARTICLE